Practice Management News

Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia compared with mindfulness sessions, according to findings published in The American Journal of Psychiatry.

Shorter primary care visits were associated with an increased likelihood of inappropriate antibiotic prescribing and coprescribing opioids and benzodiazepines, a recent study found.

The U.S. Drug Enforcement Administration, or DEA, has proposed permanent changes to rules on the prescribing of controlled substances through telehealth. The new rules would take effect when the COVID-19 public health emergency ends in May.

A new blood test may be able to detect Alzheimer’s disease-related pathology up to 10 years before symptoms appear, according to a press release from Durin Technologies.

Azstarys had a favorable safety profile, demonstrated efficacy and was well-tolerated compared to other methylphenidate products over 1 year of treatment, according to research presented in the Journal of Child and Adolescent Psychopharmacology.

A Seattle-based company announced it has secured $8 million in seed funding to promote an artificial intelligence-powered platform to assist in mental health assessments.

Let’s start by getting to the point. You should call your bank and find out what you are making on your cash.

In older adults with treatment-resistant depression, antidepressant augmentation improved well-being significantly over 10 weeks compared with switching medications and was associated with higher incidence of remission.

A Kansas-based biopharmaceutical company has announced positive top-line results from a study assessing the effect of food on absorption of its investigational extended-release tablet therapeutic CTx-1301 to treat ADHD.

Hopefully you’ve forgiven us for talking so much about tax, although by now you realize why it was so important that we did.